Delisting riskPopularity #4,702
Burning Rock Biotech (ADR) (BNR)
NGS oncology testing, hospital workflows, and biopharma development services.
$15.19
vs last close−1.26 (−7.65%)
Something off on this page? Send us feedback.
Next report
Nov 17, 26
in 55 days
EPS estimate
−$2.29
Revenue estimate
$19.2M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25Jun '25Sep '25Nov '25Mar '26Jun '26Sep '26Nov '26
Reported−$1.08−$0.17−$0.15−$0.26−$0.21−$0.20−$0.20Pending
Estimate−$1.82−$1.52−$1.49−$1.41−$1.40−$2.29−$2.29−$2.29
Surprise+40.6%+88.8%+89.9%+81.6%+85.0%+91.3%+91.3%—
RevenueReportedEstimate
Mar '25Jun '25Sep '25Nov '25Mar '26Jun '26Sep '26Nov '26
Reported$17.1M$19.7M$18.6M$18.3M$18.1M$15.7M$19.9MPending
Estimate$29.7M—$18.5M——$19.2M$19.2M$19.2M
Surprise−42.6%—+0.9%——−18.3%+3.5%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Jun 2030 | −$9.36 | — | — |
| Mar 2030 | −$9.45 | — | — |
| Dec 2029 | −$9.95 | — | — |
| Sep 2029 | −$10.20 | — | — |
| Jun 2029 | −$12.17 | — | — |
| Mar 2029 | −$12.11 | — | — |
| Dec 2028 | −$12.65 | — | — |
| Sep 2028 | −$13.55 | — | — |
| Jun 2028 | −$21.89 | — | — |
| Mar 2028 | −$17.69 | — | — |
| Dec 2027 | −$18.49 | — | — |
| Sep 2027 | −$18.90 | — | — |
| Jun 2027 | −$15.81 | — | — |
| Mar 2027 | −$16.72 | — | — |
| Dec 2026 | −$15.44 | — | — |
| Nov 2026 | −$2.29 | — | — |
| Sep 2026 | −$2.29 | −$0.20 | +91.3% |
| Jun 2026 | −$2.29 | −$0.20 | +91.3% |
| Mar 2026 | −$1.40 | −$0.21 | +85.0% |
| Nov 2025 | −$1.41 | −$0.26 | +81.6% |
| Sep 2025 | |||
| Jun 2025 | |||
| Mar 2025 | |||
| Dec 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Jun 2030 | −$9.36 | — | — | $141.4M | — | — | — |
| Mar 2030 | −$9.45 | — | — | $141.0M | — | — | — |
| Dec 2029 | −$9.95 | — | — | $140.6M | — | — | — |
| Sep 2029 | −$10.20 | — | — | $140.2M | — | — | — |
| Jun 2029 | −$12.17 | — | — | $199.0M | — | — | — |
| Mar 2029 | −$12.11 | — | — | $181.6M | — | — | — |
| Dec 2028 | −$12.65 | — | — | $159.7M | — | — | — |
| Sep 2028 | −$13.55 | — | — | $139.4M | — | — | — |
| Jun 2028 | −$21.89 | — | — | $108.7M | — | — | — |
| Mar 2028 | −$17.69 | — | — | $144.5M | — | — | — |
| Dec 2027 | −$18.49 | — | — | $151.9M | — | — | — |
| Sep 2027 | −$18.90 | — | — | $146.1M | — | — | — |
| Jun 2027 | −$15.81 | — | — | $143.9M | — | — | — |
| Mar 2027 | −$16.72 | — | — | $134.0M | — | — | — |
| Dec 2026 | −$15.44 | — | — | $144.1M | — | — | — |
| Nov 17, 2026 | −$2.29 | — | — | $19.2M | — | — | — |
| Sep 10, 2026 | −$2.29 | −$0.20 | +91.3% | $19.2M | $19.9M | +3.5% | −3.1% |
| Jun 9, 2026 | −$2.29 | −$0.20 | +91.3% | $19.2M | $15.7M | −18.3% | −9.8% |
| Mar 12, 2026 | −$1.40 | −$0.21 | +85.0% | — | $18.1M | — | −2.6% |
| Nov 20, 2025 | −$1.41 | −$0.26 | +81.6% | — | $18.3M | — | −3.1% |
| Sep 8, 2025 | |||||||
| Jun 6, 2025 | |||||||
| Mar 25, 2025 | |||||||
| Dec 3, 2024 | |||||||
| Aug 22, 2024 | |||||||
| May 29, 2024 | |||||||
| Mar 28, 2024 | |||||||
| Nov 21, 2023 | |||||||
| Aug 30, 2023 | |||||||
| May 30, 2023 | |||||||
| Mar 28, 2023 | |||||||
| Nov 15, 2022 | |||||||
| Aug 31, 2022 | |||||||
| May 31, 2022 | |||||||
| Mar 21, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Aug 31, 2021 | |||||||
| May 25, 2021 | |||||||
| Mar 10, 2021 | |||||||
| Nov 20, 2020 | |||||||
| Aug 11, 2020 | |||||||
| Jun 12, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 |